A drug recall is underway in about two dozen countries after an ingredient manufactured by a Chinese company was found to be tainted with a carcinogenic chemical.
The European Medicines Agency announced on July 5 that a number of medicines for high blood pressure and heart conditions containing valsartan and manufactured by the Chinese company Zhejiang Huahai Pharmaceuticals are being recalled across Europe because they contain an impurity called N-nitrosodimethylamine (NDMA) that is carcinogenic, according to Reuters.
